导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -4.41% | 687/1050 |
| 近一周 | -2.06% | 433/1104 |
| 近一月 | -0.27% | 99/1102 |
| 近一季 | -1.46% | 308/1092 |
| 近半年 | -5.98% | 650/1070 |
| 近一年 | -11.27% | 759/1018 |
| 近两年 | 24.12% | 733/926 |
| 近三年 | 11.56% | 583/834 |
| 成立以来 | 144.64% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.57% 787/1070 |
-8.31% 875/1101 |
- - |
- - |
| 2025 | 9.66% 833/1065 |
3.83% 492/1014 |
1.24% 580/1038 |
10.77% 838/1050 |
-5.83% 731/1065 |
| 2024 | 16.56% 138/1011 |
4.88% 107/960 |
5.09% 91/983 |
11.19% 532/991 |
-4.88% 662/1011 |
| 2023 | -1.96% 136/952 |
5.02% 325/880 |
0.02% 190/895 |
0.14% 82/915 |
-6.79% 655/952 |
| 2022 | -6.36% 42/867 |
1.67% 4/773 |
3.87% 586/806 |
-12.18% 402/845 |
0.97% 385/867 |
| 2021 | 11.19% 228/740 |
7.06% 30/580 |
-2.11% 564/659 |
3.49% 156/704 |
2.52% 334/740 |
| 2020 | 20.19% 382/554 |
-8.13% 360/419 |
6.37% 410/466 |
16.82% 113/517 |
5.28% 433/554 |
| 2019 | 42.26% 202/410 |
31.34% 298/1146 |
-3.86% 637/1228 |
-0.92% 355/390 |
13.71% 79/410 |
| 2018 | -20.05% 81/349 |
- - |
-7.42% 296/990 |
-3.13% 377/1000 |
-10.72% 356/1080 |
| 2017 | 43.21% 12/285 |
- - |
- - |
- - |
- - |
| 2016 | -15.89% 98/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 安信新常态股票A VS. 东吴新产业精选股票A(580008) |